Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

ANEBULO PHARMACEUTICALS, INC. (ANEB) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

ANEBULO PHARMACEUTICALS, INC. (ANEB), most recent 12 months reported: net loss $7.98M. Latest balance sheet on file: liquid cash $9.04M. From SEC filings. Others in Pharmaceutical Preparations: ALDEYRA THERAPEUTICS, INC. · ALX ONCOLOGY HOLDINGS INC · ALZAMEND NEURO, INC. · Amylyx Pharmaceuticals, Inc. · ANIXA BIOSCIENCES, INC. · ANNEXON, INC. · Alto Neuroscience, Inc. · AN2 Therapeutics, Inc.

Stock screener

Watchlist